Skip to main content
JHX
NYSE Manufacturing

James Hardie Q2 FY27: Sales Up 24%, EBITDA Margin 31.8%, FCF Target Raised to $650M+

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Building Materials Stocks · Materials
Sentiment info
Positive
Importance info
8
Price
$28
Mkt Cap
$16.638B
52W Low
$16.46
52W High
$31.43
52W Position info
70% above low
Off High info
11% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

JHX sits 70% above its 52-week low of $16.46.

Summary

James Hardie beat the high end of Q2 FY27 guidance on sales and Adjusted EBITDA margin, reaffirmed full-year FY27, and raised its free cash flow target to more than $650 million while accelerating deleveraging.


Key Events · Earnings and Guidance · JHX

  • Q2 FY27 Beat at High End

    Continuing-operations net sales of $1,428.2 million rose 24% year over year and landed at the high end of guidance; Adjusted EBITDA of $454.7 million produced a 31.8% margin, above the high end and up 450 basis points.

  • Free Cash Flow Target Raised

    FY27 free cash flow target lifted to more than $650 million; first-half free cash flow was $535.4 million versus $58.4 million a year earlier.

  • Deleveraging Ahead of Schedule

    $111 million of term loan debt was repaid in the quarter, reaching the FY27 leverage target early; management still targets net leverage below 2.0x by the end of Q2 FY2028, aided by roughly $600 million of expected Europe divestiture proceeds.

  • Q3 Guidance Steps Down

    Q3 FY27 total net sales guided to $1.058-$1.140 billion and Adjusted EBITDA to $298-$320 million, reflecting DR&A seasonality, higher freight costs and a weaker macro environment.


Analysis · JHX · Manufacturing

Sales from continuing operations of $1.428B landed at the high end of guidance, and Adjusted EBITDA of $454.7M at a 31.8% margin beat the top of the range, with Siding & Trim sales of $880.3M also above guidance. Management reaffirmed full-year FY27 sales and Adjusted EBITDA and lifted the free cash flow target to more than $650 million, while first-half free cash flow of $535.4M and $111M of term-loan repayment put the sub-2.0x net leverage goal ahead of schedule. The offset is a softer second half: Q3 Adjusted EBITDA is guided to $298-$320M on DR&A seasonality, higher freight and a weaker macro backdrop, so the beat is being partly given back in the near term.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, JHX was trading at $28.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $16.6B. The 52-week trading range was $16.46 to $31.43. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

JHX - Latest Insights

JHX
Nov 05, 2026, 4:19 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $27.97
Real-time Price: $26.77 info
Change: -$1.20 (-4%) info
Market Cap: $15.571B info
JHX
Nov 05, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $28.66
Real-time Price: $26.77 info
Change: -$1.89 (-7%) info
Market Cap: $15.571B info
JHX
Sep 15, 2026, 8:52 AM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $28.14
Real-time Price: $26.77 info
Change: -$1.37 (-5%) info
Market Cap: $15.571B info
JHX
Aug 20, 2026, 4:36 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $30.34
Real-time Price: $26.77 info
Change: -$3.57 (-12%) info
Market Cap: $15.571B info
JHX
Aug 14, 2026, 4:23 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $30.80
Real-time Price: $26.77 info
Change: -$4.03 (-13%) info
Market Cap: $15.571B info